[1]
|
Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297.
https://doi.org/10.1016/S0092-8674(04)00045-5
|
[2]
|
Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. https://doi.org/10.1016/0092-8674(93)90529-Y
|
[3]
|
Reinhart, B.J., Slack, F.J., Basson, M., et al. (2000) The 21-Nucleotide let-7 RNA Regulates Developmental Timing in Caenorhabditis elegans. Nature, 403, 901-906. https://doi.org/10.1038/35002607
|
[4]
|
Goodall, G.J. and Wickramasinghe, V.O. (2021) RNA in Cancer. Nature Reviews Cancer, 21, 22-36.
https://doi.org/10.1038/s41568-020-00306-0
|
[5]
|
Pritchard, C.C., Cheng, H.H. and Tewari, M. (2012) MicroRNA Profiling: Approaches and Considerations. Nature Reviews Genetics, 13, 358-369. https://doi.org/10.1038/nrg3198
|
[6]
|
Lan, H., Lu, H., Wang, X., et al. (2015) MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International, 2015, Article ID: 125094. https://doi.org/10.1155/2015/125094
|
[7]
|
Li, Y., Li, L., Qian, Z., et al. (2018) Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Fac-tor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells. Journal of the American Heart As-sociation, 7, e007572.
https://doi.org/10.1161/JAHA.117.007572
|
[8]
|
Pignot, G., et al. (2013) microRNA Expression Profile in a Large Series of Bladder Tumors: Identification of a 3- miRNA Signature Associated with Aggressiveness of Muscle-Invasive Bladder Cancer. International Journal of Cancer, 132, 2479-2491. https://doi.org/10.1002/ijc.27949
|
[9]
|
Farabaugh, S.M., Chan, B.T., Cui, X., et al. (2016) Lack of Interaction be-tween ErbB2 and Insulin Receptor Substrate Signaling in Breast Cancer. Cell Communication and Signaling: CCS, 14, Article No. 25.
https://doi.org/10.1186/s12964-016-0148-8
|
[10]
|
Gao, S.-B., Li, K.-L., Qiu, H., et al. (2017) Enhancing Chemo-therapy Sensitivity by Targeting PcG via the ATM/p53 Pathway. American Journal of Cancer Research, 7, 1874-1883.
|
[11]
|
Gruber, W., Scheidt, T., Aberger, F., et al. (2017) Understanding Cell Signaling in Cancer Stem Cells for Targeted Therapy—Can Phosphoproteomics Help to Reveal the Secrets? Cell Communication and Signaling: CCS, 15, Article No. 12. https://doi.org/10.1186/s12964-017-0166-1
|
[12]
|
Järvelin, A.I., Noerenberg, M., Davis, I., et al. (2016) The New (Dis)order in RNA Regulation. Cell Communication and Signaling: CCS, 14, Article No. 9. https://doi.org/10.1186/s12964-016-0132-3
|
[13]
|
Smyth, E.C., Nilsson, M., Grabsch, H.I., et al. (2020) Gastric Cancer. The Lancet, 396, 635-648.
https://doi.org/10.1016/S0140-6736(20)31288-5
|
[14]
|
Liu, G., Jiang, Z., Qiao, M., et al. (2019) Lnc-GIHCG Pro-motes Cell Proliferation and Migration in Gastric Cancer through miR-1281 Adsorption. Molecular Genetics & Genomic Medicine, 7, e711. https://doi.org/10.1002/mgg3.711
|
[15]
|
Kaul, A., Schuster, E. and Jennings, B.H. (2014) The Groucho Co-Repressor Is Primarily Recruited to Local Target Sites in Active Chromatin to Attenuate Transcription. PLoS Genetics, 10, e1004595.
https://doi.org/10.1371/journal.pgen.1004595
|
[16]
|
Yao, X., Ireland, S.K., Pham, T., et al. (2014) TLE1 Promotes EMT in A549 Lung Cancer Cells through Suppression of E-Cadherin. Biochemical and Biophysical Research Commu-nications, 455, 277-284.
https://doi.org/10.1016/j.bbrc.2014.11.007
|
[17]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[18]
|
Harbeck, N., Penault-Llorca, F., Cortes, J., et al. (2019) Breast Cancer. Nature Reviews. Disease Primers, 5, Article No. 66. https://doi.org/10.1038/s41572-019-0111-2
|
[19]
|
Medeiros, B. and Allan, A.L. (2019) Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Per-spectives. International Journal of Molecular Sciences, 20, E2272.
https://doi.org/10.3390/ijms20092272
|
[20]
|
Fan, L.-Y., Shi, K.-Y., Xu, D., et al. (2019) LncRNA GIHCG Regu-lates microRNA-1281 and Promotes Malignant Progression of Breast Cancer. European Review for Medical and Phar-macological Sciences, 23, 10842-10850.
|
[21]
|
Bao, P.P., et al. (2019) Incidence and Mortality of Sarcomas in Shanghai, China, during 2002-2014. Frontiers in Oncology, 9, Article No. 662. https://doi.org/10.3389/fonc.2019.00662
|
[22]
|
Lancia, C., Anninga, J.K., Sydes, M.R., et al. (2019) A Novel Method to Address the Association between Received Dose Intensity and Survival Outcome: Benefits of Approaching Treatment Intensification at a More Individualised Level in a Trial of the European Osteosarcoma Intergroup. Cancer Chemotherapy and Pharmacology, 83, 951-962.
https://doi.org/10.1007/s00280-019-03797-3
|
[23]
|
Gill, J. and Gorlick, R. (2021) Advancing Therapy for Osteo-sarcoma. Nature Reviews Clinical Oncology, 18, 609-624.
https://doi.org/10.1038/s41571-021-00519-8
|
[24]
|
Jiang, J., Ma, B., Li, X., et al. (2018) MiR-1281, a p53-Responsive microRNA, Impairs the Survival of Human Osteosarcoma Cells upon ER Stress via Targeting USP39. American Journal of Cancer Research, 8, 1764-1774.
|
[25]
|
Ostrom, Q.T., Gittleman, H., Truitt, G., et al. (2018) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro-Oncology, 20, iv1-iv86.
https://doi.org/10.1093/neuonc/noy131
|
[26]
|
Tan, A.C., Ashley, D.M., López, G.Y., et al. (2020) Management of Glioblastoma: State of the Art and Future Directions. CA: A Cancer Journal for Clinicians, 70, 299-312. https://doi.org/10.3322/caac.21613
|
[27]
|
Hu, G., Liu, N., Wang, H., et al. (2019) LncRNA LINC01857 Promotes Growth, Migration, and Invasion of Glioma by Modulating miR-1281/TRIM65 Axis. Journal of Cellular Physiology, 234, 22009-22016.
https://doi.org/10.1002/jcp.28763
|
[28]
|
Ferlay, J., Colombet, M., Soerjomataram, I., et al. (2019) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953.
https://doi.org/10.1002/ijc.31937
|
[29]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[30]
|
Johnson, D.E., Burtness, B., Leemans, C.R., et al. (2020) Head and Neck Squamous Cell Carcinoma. Nature Reviews Disease Primers, 6, Article No. 92. https://doi.org/10.1038/s41572-020-00224-3
|
[31]
|
Hufbauer, M., Maltseva, M., Meinrath, J., et al. (2018) HPV16 Increases the Number of Migratory Cancer Stem Cells and Modulates Their miRNA Expression Profile in Oropharynge-al Cancer. International Journal of Cancer, 143, 1426- 1439. https://doi.org/10.1002/ijc.31538
|